Summary
This 8-K filing from CVS Health Corp. (CVS) announces a significant change in its financial leadership. Eva C. Boratto, previously Senior Vice President of PBM Finance, has been appointed Senior Vice President – Controller and Chief Accounting Officer (CAO). This role was temporarily held by the CFO, David M. Denton, who will now fully concentrate on his CFO responsibilities. Ms. Boratto's promotion is effective immediately and comes with an increased salary and incentive compensation, reflecting her expanded duties. Investors should note this transition as it pertains to internal financial reporting and controls. Ms. Boratto's extensive experience, including nearly 20 years at Merck & Co., Inc., suggests a solid foundation for her new role. The company's decision to move these responsibilities back to a dedicated CAO, separate from the CFO's primary duties, could signal a focus on strengthening financial oversight and reporting processes.
Key Highlights
- 1Eva C. Boratto appointed Senior Vice President – Controller and Chief Accounting Officer (CAO), effective immediately.
- 2David M. Denton, CFO, relinquishes the interim Controller and CAO duties to focus solely on his CFO role.
- 3Ms. Boratto's annual salary increased to $500,000 upon her appointment.
- 4Her 2013 target annual cash incentive award increased to 55% of her salary.
- 5Ms. Boratto will continue to participate in equity incentive plans at levels consistent with her prior position.
- 6Ms. Boratto has nearly 20 years of experience, including significant roles at Merck & Co., Inc.
- 7The appointment indicates a formalization of the CAO role separate from the CFO position.